Gene: SEMA3E

9723
M-SEMAH|M-SemaK|SEMAH|coll-5
semaphorin 3E
protein-coding
7q21.11
Ensembl:ENSG00000170381 MIM:608166 Vega:OTTHUMG00000154693 UniprotKB:O15041
NG_021242.1
SNP Mapped
ND
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
9.280e-1 (AD)  6.039e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs2247219chr7:83438154 (GRCh38.p7)T>Gnicotine dependenceSNV(Single Nucleotide Variation)

DNA Methylation

Probe Locus(GRCh37) Gene Region p-val Trait PubMed ID
cg07449753chr7:83057120SEMA3EGene body5.573e-4Alcohol use disorders26763658

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
DACH10.842
FOXP20.836
MCTP20.83
THEMIS0.82
CHN20.81
TNIP30.801
FILIP10.796
NPFFR20.794
CYP26A10.778
GRIK30.769

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
MSX1-0.481
ZIC2-0.45
TFAP2C-0.446
ASB4-0.437
OAF-0.432
ENDOU-0.416
NR2E1-0.412
ZIC5-0.41
EMX2-0.408
IMPA2-0.408

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C5486512-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of SEMA3E mRNA19933214
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C4591794-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C516138(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
D000082AcetaminophenAcetaminophen results in decreased expression of SEMA3E mRNA29067470
D000082AcetaminophenAcetaminophen affects the expression of SEMA3E mRNA17562736
D016604Aflatoxin B1Aflatoxin B1 results in decreased methylation of SEMA3E gene27153756
D000393Air PollutantsAir Pollutants analog results in decreased expression of SEMA3E mRNA21757418
D001280AtrazineAtrazine results in decreased expression of SEMA3E mRNA25929836
C487081belinostatbelinostat results in increased expression of SEMA3E mRNA26272509
C487081belinostat"[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C022921benzo(k)fluoranthenebenzo(k)fluoranthene results in decreased expression of SEMA3E mRNA26377693
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased methylation of SEMA3E promoter28329817
D001564Benzo(a)pyreneBenzo(a)pyrene results in decreased expression of SEMA3E mRNA23735875
C006780bisphenol Abisphenol A results in decreased expression of SEMA3E mRNA25181051
C006780bisphenol Abisphenol A results in increased methylation of SEMA3E gene28505145
D002794Choline[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SEMA3E gene20938992
D003042CocaineCocaine affects the expression of SEMA3E mRNA15691709
D016572CyclosporineCyclosporine results in decreased expression of SEMA3E mRNA20106945
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of SEMA3E mRNA27392435
D002945CisplatinCisplatin results in decreased expression of SEMA3E mRNA27392435
C118739entinostatentinostat results in increased expression of SEMA3E mRNA26272509
C118739entinostat"[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
D005485FlutamideFlutamide results in decreased expression of SEMA3E mRNA24793618
D005492Folic Acid[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SEMA3E gene20938992
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of SEMA3E mRNA27392435
C544151jinfukangjinfukang results in decreased expression of SEMA3E mRNA27392435
C561695(+)-JQ1 compound(+)-JQ1 compound results in decreased expression of SEMA3E mRNA23430699|2479639
C008261lead acetatelead acetate results in increased expression of SEMA3E mRNA25270620
D058185Magnetite Nanoparticles[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA3E mRNA21641980
C042720mercuric bromidemercuric bromide results in increased expression of SEMA3E mRNA26272509
C042720mercuric bromide"[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
D008715Methionine[Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SEMA3E gene20938992
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in decreased expression of SEMA3E mRNA26011545
D0156551-Methyl-4-phenylpyridinium1-Methyl-4-phenylpyridinium results in decreased expression of SEMA3E mRNA24810058
C517284monomethyl phthalatemonomethyl phthalate affects the expression of SEMA3E mRNA26924002
D009151Mustard GasMustard Gas results in decreased expression of SEMA3E mRNA15674843
D037742Nanotubes, Carbon"Nanotubes, Carbon analog results in decreased expression of SEMA3E mRNA"25554681
D037742Nanotubes, Carbon"Nanotubes, Carbon results in decreased expression of SEMA3E mRNA"25554681
D009532NickelNickel results in decreased expression of SEMA3E mRNA24768652|2558310
C496932panobinostat"[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C496932panobinostatpanobinostat results in increased expression of SEMA3E mRNA26272509
C086401pentabromodiphenyl etherpentabromodiphenyl ether results in decreased expression of SEMA3E mRNA26705709
C023036perfluorooctanoic acidperfluorooctanoic acid results in increased expression of SEMA3E mRNA28511854
D010634PhenobarbitalPhenobarbital affects the expression of SEMA3E mRNA19159669
D010662Phenylmercuric Acetate"[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
D010662Phenylmercuric AcetatePhenylmercuric Acetate results in increased expression of SEMA3E mRNA26272509
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SEMA3E mRNA19710929
C017947sodium arsenitesodium arsenite affects the methylation of SEMA3E gene28589171
C017947sodium arsenitesodium arsenite results in increased expression of SEMA3E mRNA17879257
D004113Succimer[Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA3E mRNA21641980
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of SEMA3E mRNA11007951
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in decreased expression of SEMA3E mRNA19933214
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin results in increased expression of SEMA3E mRNA19770486
C009495titanium dioxidetitanium dioxide results in decreased expression of SEMA3E mRNA23557971|2776080
D014118Toxins, Biological"Toxins, Biological affects the expression of SEMA3E mRNA"19682533
D014212TretinoinTretinoin results in increased expression of SEMA3E mRNA16604517
D014241TrichloroethyleneTrichloroethylene results in increased methylation of SEMA3E gene27618143
C012589trichostatin A"[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C012589trichostatin Atrichostatin A results in increased expression of SEMA3E mRNA24935251|2627250
D014635Valproic Acid"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
D014635Valproic AcidValproic Acid affects the expression of SEMA3E mRNA25979313
D014635Valproic AcidValproic Acid results in increased expression of SEMA3E mRNA23179753|2438349
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of SEMA3E gene25560391
C029297vinylidene chloridevinylidene chloride results in decreased expression of SEMA3E mRNA26682919
C111237vorinostat"[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SEMA3E mRNA"27188386
C111237vorinostatvorinostat results in increased expression of SEMA3E mRNA26272509
D015032ZincZinc deficiency results in increased expression of SEMA3E mRNA22171008

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0005515protein binding-IPI17318185  
GO:0030215semaphorin receptor binding-IBA21873635  
GO:0038191neuropilin binding-IBA21873635  
GO:0045499chemorepellent activity-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0001569branching involved in blood vessel morphogenesis-ISS-  
GO:0001755neural crest cell migration-IBA21873635  
GO:0001953negative regulation of cell-matrix adhesion-ISS-  
GO:0002040sprouting angiogenesis-ISS-  
GO:0007399nervous system development-IEA-  
GO:0008360regulation of cell shape-ISS-  
GO:0016525negative regulation of angiogenesis-ISS-  
GO:0030154cell differentiation-IEA-  
GO:0030335positive regulation of cell migration-IBA21873635  
GO:0048843negative regulation of axon extension involved in axon guidance-IBA21873635  
GO:0050808synapse organization-ISS-  
GO:0050919negative chemotaxis-IBA21873635  
GO:0071526semaphorin-plexin signaling pathway-IBA21873635  
GO:0071526semaphorin-plexin signaling pathway-ISS-  
GO:2000249regulation of actin cytoskeleton reorganization-ISS-  
GO ID GO Term Qualifier Evidence PubMed
GO:0005576extracellular region-TAS-  
GO:0005615extracellular space-IBA21873635  
GO:0005887integral component of plasma membrane-IBA21873635  
KEGG ID KEGG Term
hsa04360Axon guidance
Reactome ID Reactome Term Evidence
R-HSA-1266738Developmental BiologyTAS
R-HSA-373755Semaphorin interactionsTAS
R-HSA-416700Other semaphorin interactionsTAS
R-HSA-422475Axon guidanceTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal